Clinical Trial Update: Pembro With Radiation With or Without Olaparib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates pembrolizumab with radiation, with or without olaparib, for prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Olaparib (Olaparib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Zin W Myint | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING